Oncolytics Announces the Anal Cancer Cohort of the GOBLET Phase 1/2 Study of Pelareorep and Atezolizumab Has Met the Success Criteria for Efficacy

[ad_1] Pelareorep-atezolizumab combination data exceeds historical control trials with a 37.5% objective response rate, including a complete response SAN DIEGO and CALGARY, Alberta, Nov. 9, 2023 /PRNewswire/ — Oncolytics Biotech® Inc.…

Neogap Therapeutics from Sweden receives €7.1M funding boost for personalized cancer treatment research – ArcticStartup

[ad_1] – Advertisement – Neogap Therapeutics, a Stockholm-headquartered biotech company, has secured €7.1 million (SEK 83 million) for its clinical phase I/II cancer study, with €4.64 million (54MSEK) from a…

Wuxi Biologics Unit’s Hong Kong IPO Closes Order Book a Day Early, Sources Say

[ad_1] A unit of Chinese contract drugmaker Wuxi Biologics closed its order book a day early for its initial public offering and is likely to price the deal at the…

Breaking the Mold: Why Non-Linear Career Paths Create Leaders of the Future – MedCity News

[ad_1] As the responsibilities of leaders become more complex and ambiguous, it’s worth asking: is the straight and narrow career path still the optimal one for developing tomorrow’s leaders? In…

CCOB students help over 48,000 stand up to cancer at World Series – GCU News

[ad_1] Colangelo College of Business students played a prominent role in the Stand Up to Cancer event at Game 4 of the World Series. The Arizona Diamondbacks failed to earn…

Report: Percentage of Workers Eligible for Employment-Based Coverage Increased 5% Since 2014 – MedCity News

[ad_1] It was expected that after the Patient Protection and Affordable Care Act of 2010 was implemented, many employers would stop offering workplace health insurance. But that wasn’t the case,…

RCM Staff Shortages Are Making It a Lot Harder for Providers to Get Paid – MedCity News

[ad_1] Healthcare’s workforce shortage is one of the most pressing — perhaps the most pressing — issue plaguing the industry. Discussions around this topic usually center around providers’ lack of…

Why GLP-1s Alone Cannot Solve the Obesity Crisis – MedCity News

[ad_1] GLP-1s are making headlines and are in high demand for their ability to help people lose weight, with five million prescriptions written in 2022. For many people who’ve struggled…

Urban Institute: 400,000 Veterans Expected to be Uninsured in 2024 – MedCity News

[ad_1] About 5% of nonelderly veterans are projected to be uninsured in 2024, according to a new Urban Institute report. This represents about 400,000 individuals. More than half, or 52.3%,…

Race for the Cure Cyprus 2023 announced to support breast cancer awareness

[ad_1] In a press conference held at the Char. Pilakoutas Heritage on Friday, November 3, the organization of this year’s Race for the Cure in Cyprus was officially announced. The…